Burning Rock Biotech Limited (BNR)
USD 2.79
(-2.79%)
USD 2.79
(-2.79%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -517.9 Million CNY | 47.3% |
| 2022 | -856.31 Million CNY | -23.76% |
| 2021 | -746.49 Million CNY | -94.83% |
| 2020 | -373.25 Million CNY | -198.6% |
| 2019 | -136.38 Million CNY | -0.38% |
| 2018 | -135.86 Million CNY | -37.18% |
| 2017 | -99.55 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -125.81 Million CNY | 37.1% |
| 2024 Q2 | -111.47 Million CNY | -19.91% |
| 2023 Q3 | -179.23 Million CNY | -37.26% |
| 2023 Q1 | -184.71 Million CNY | 13.96% |
| 2023 Q2 | -130.58 Million CNY | 29.3% |
| 2023 FY | - CNY | 47.3% |
| 2023 Q4 | -147.78 Million CNY | 17.55% |
| 2022 Q4 | -214.68 Million CNY | 9.02% |
| 2022 Q3 | -235.98 Million CNY | 10.15% |
| 2022 Q2 | -262.64 Million CNY | -0.22% |
| 2022 FY | - CNY | -23.76% |
| 2022 Q1 | -262.08 Million CNY | -4.22% |
| 2021 FY | - CNY | -94.83% |
| 2021 Q4 | -251.47 Million CNY | -47.87% |
| 2021 Q3 | -170.06 Million CNY | 15.35% |
| 2021 Q2 | -200.91 Million CNY | -17.52% |
| 2021 Q1 | -170.95 Million CNY | -10.5% |
| 2020 Q2 | -72.87 Million CNY | -30.75% |
| 2020 FY | - CNY | -198.6% |
| 2020 Q1 | -55.73 Million CNY | 44.93% |
| 2020 Q4 | -154.71 Million CNY | -24.64% |
| 2020 Q3 | -124.12 Million CNY | -70.32% |
| 2019 Q2 | -24.99 Million CNY | -446.31% |
| 2019 Q4 | -101.2 Million CNY | -238.33% |
| 2019 Q3 | -29.91 Million CNY | -19.66% |
| 2019 Q1 | -4.57 Million CNY | 89.24% |
| 2019 FY | - CNY | -0.38% |
| 2018 FY | - CNY | -37.18% |
| 2018 Q4 | -42.54 Million CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -117.56 Million USD | -340.523% |
| Biodesix, Inc. | -37.1 Million USD | -1295.847% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -6688.312% |
| Castle Biosciences, Inc. | -45.02 Million USD | -1050.278% |
| DarioHealth Corp. | -53.49 Million USD | -868.148% |
| Exact Sciences Corporation | 41.87 Million USD | 1336.749% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 142.532% |
| Illumina, Inc. | -608 Million USD | 14.819% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -5778.087% |
| iSpecimen Inc. | -9.1 Million USD | -5588.894% |
| Standard BioTools Inc. | -54.45 Million USD | -851.027% |
| 23andMe Holding Co. | -291.87 Million USD | -77.44% |
| Medpace Holdings, Inc. | 363.15 Million USD | 242.612% |
| NeoGenomics, Inc. | -17.6 Million USD | -2841.449% |
| Inotiv, Inc. | -26.5 Million USD | -1853.901% |
| Psychemedics Corporation | -251 Thousand USD | -206235.06% |
| Prenetics Global Limited | -47.89 Million USD | -981.301% |
| Precipio, Inc. | -4.31 Million USD | -11894.002% |
| RadNet, Inc. | 292.78 Million USD | 276.887% |
| Sotera Health Company | 514.14 Million USD | 200.731% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -30599.526% |
| Exagen Inc. | -19.15 Million USD | -2604.02% |
| Natera, Inc. | -383.27 Million USD | -35.125% |
| Aspira Women's Health Inc. | -16.49 Million USD | -3040.507% |
| Neogen Corporation | 182.59 Million USD | 383.631% |
| Myriad Genetics, Inc. | -67.8 Million USD | -663.866% |
| ICON Public Limited Company | 1.63 Billion USD | 131.741% |
| Bionano Genomics, Inc. | -213.6 Million USD | -142.458% |
| CareDx, Inc | -89.65 Million USD | -477.647% |
| Check-Cap Ltd. | -17.64 Million USD | -2834.45% |
| Twist Bioscience Corporation | -176.7 Million USD | -193.088% |
| Guardant Health, Inc. | -433.3 Million USD | -19.523% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -20739.736% |
| Fulgent Genetics, Inc. | -46.55 Million USD | -1012.521% |
| Sera Prognostics, Inc. | -35.28 Million USD | -1367.682% |
| OPKO Health, Inc. | -65.51 Million USD | -690.495% |
| Personalis, Inc. | -96.8 Million USD | -434.983% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -5299.841% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -30599.526% |
| MDxHealth SA | -30.46 Million USD | -1599.819% |
| Prenetics Global Limited | -47.89 Million USD | -981.301% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -5192.911% |
| Mainz Biomed B.V. | -25.01 Million USD | -1970.676% |
| Trinity Biotech plc | -24.09 Million USD | -2049.145% |
| Neuronetics, Inc. | -22.75 Million USD | -2175.588% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -6688.312% |